Silent myocardial ischemia in type 2 diabetic patients :: benefits of intensive treatment of cardiovascular risk factors and optimal glycemic equilibrium

被引：0
|
作者：
Jacqueminet, S. [1 ]
Barthelemy, O. [2 ]
Rouzet, F. [3 ]
Isnard, R. [2 ]
Halbron, M. [1 ]
Bouzamondo, A. [4 ]
Le Guludec, D. [3 ]
Grimaldi, A. [1 ]
Metzger, J. P. [2 ]
Le Feuvre, C. [2 ]
机构：
[1] Grp Hosp Pitie Salpetriere, Serv Diabetol Nutr & Malad Metab, F-75634 Paris, France
[2] Grp Hosp Pitie Salpetriere, Inst Cardiol, F-75634 Paris, France
[3] Hop Bichat Claude Bernard, Nucl Med Serv, F-75877 Paris, France
[4] Grp Hosp Pitie Salpetriere, Serv Pharmacol, F-75634 Paris, France
来源：
DIABETES & METABOLISM | 2008年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P4
引用
收藏
页码：A40 / A41
页数：2
相关论文
共 50 条
  • [31] Impact of a multidisciplinary intensive education program on type 2 diabetes mellitus patients' glycemic control and cardiovascular risk factors
    Al-Arifi, Mohamed N.
    Al-Omar, Hussain A.
    SAUDI MEDICAL JOURNAL, 2018, 39 (07) : 705 - 710
  • [32] L-Selectin is a marker of silent myocardial ischemia in diabetic patients and is not influenced by glycemic control.
    Albertini, JP
    Cosson, E
    Gattegno, L
    Berteau, P
    Attali, JR
    Valensi, P
    DIABETOLOGIA, 2000, 43 : A286 - A286
  • [33] Clinical and metabolic predictors of silent myocardial ischemia in type 2 diabetic males
    Mamcarz, A
    Braksator, W
    Kuch, M
    Krol, J
    Chmielewski, M
    Kuch, J
    Leowski, J
    Szczeklik, Z
    Walasik, L
    Taton, J
    23RD CONGRESS OF THE INTERNATIONAL SOCIETY OF INTERNAL MEDICINE, 1996, : 89 - 92
  • [34] Relationship between erectile dysfunction, cardiovascular risk factors, and silent myocardial ischemia in type 2 diabetes: Insights from the DIAD study
    Asnani, S
    Campeau, R
    Shankar, A
    Engel, S
    Chyun, D
    Inzucchi, S
    Young, L
    Wackers, F
    Fonseca, V
    DIABETES, 2005, 54 : A163 - A164
  • [35] Role of coronary artery calcium score in the detection of silent myocardial ischemia in diabetic patients with high cardiovascular risk.
    Bouzidi, A.
    Belakroum, R.
    Zehnati, T.
    Merghit, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S613 - S613
  • [36] Lack of correlation be tween the prevalence of silent myocardial ischemia and the cardiovascular risk found from the Framingham equation in diabetic patients
    Marechaud, R
    Torremocha, F
    BouinPineau, MH
    Herpin, D
    Rosenberg, T
    Kharitonnoff, T
    Carrie, F
    Muller, A
    ATHEROSCLEROSIS, 1997, 134 (1-2) : 88 - 89
  • [37] Need to improve the treatment of cardiovascular risk factors in type 2 diabetic patients with nephropathy.
    Carrera, MJ
    Gómez, N
    Micaló, T
    Sahún, M
    Vinzia, C
    Montanya, E
    Prat, CAP
    DIABETOLOGIA, 1998, 41 : A292 - A292
  • [38] Selecting asymptomatic type 2 diabetic patients or screening for silent myocardial ischaemia:: what risk factors should be considered?
    Sultan, A.
    Piot, C.
    Dieudonne, J. Thuan dit
    Mariano-Goulard, D.
    Renard, E.
    Avignon, A.
    DIABETOLOGIA, 2006, 49 : 706 - 707
  • [39] Impact of gender on the treatment of cardiovascular risk factors in type 2 diabetic patients in daily practice
    Jungmann, E.
    Bolle, J.
    Jungmann, G.
    Schmitz, C.
    Snelting, U.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2007, 115 : S24 - S24
  • [40] Can myocardial performance index predict the presence of silent ischemia in asymptomatic type 2 diabetic patients?
    Al-Daydamony, Mohammad M.
    El-Tahlawi, Mohammad A.
    Shawky, Ahmad
    ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2016, 33 (12): : 1823 - 1827
12345